Encapsulating peritoneal sclerosis associated with Burkholderia pseudomallei peritonitis

Zakaria Aulia1, Wan Ahmad Syahril Rozli Wan Ali1, Mohammad Arif Shahar1

  • 1Department of Internal Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Pahang, Malaysia.

Insights

Melioidosis, a serious infection caused by Burkholderia pseudomallei, rarely affects patients undergoing peritoneal dialysis (PD). This case highlights a PD patient who developed PD peritonitis and encapsulating peritoneal sclerosis, emphasizing the need for early diagnosis and appropriate antibiotic therapy.

Area of Science:

  • Infectious Diseases
  • Nephrology
  • Microbiology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is an infectious disease endemic in tropical regions, typically affecting immunocompromised individuals.
  • End-stage renal disease (ESRD) patients on peritoneal dialysis (PD) are at increased risk for infectious complications.
  • Peritonitis is a common complication in PD patients, often caused by bacterial infections.

Observation:

  • A rare case of a patient with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD) who presented with melioidosis peritonitis.
  • The patient rapidly developed encapsulating peritoneal sclerosis (EPS), a severe complication characterized by intraabdominal cocooning.
  • Burkholderia pseudomallei was identified as the causative agent of the peritonitis.

Findings:

  • This report details a unique presentation of melioidosis in a CAPD patient, leading to severe outcomes including peritonitis and EPS.
  • The study underscores the potential for unusual pathogens like Burkholderia pseudomallei to cause serious infections in PD patients.
  • Intraoperative findings confirmed intraabdominal cocooning, indicative of advanced encapsulating peritoneal sclerosis.

Implications:

  • Early diagnosis and prompt, appropriate antibiotic treatment are crucial for managing melioidosis peritonitis and preventing complications like EPS in PD patients.
  • This case highlights the importance of considering melioidosis in the differential diagnosis of peritonitis in PD patients, especially in endemic areas.
  • Optimizing antibiotic choice and duration is critical for successful eradication of Burkholderia pseudomallei and improving patient prognosis.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
754
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.0K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
806
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
511